Skip to main content

Problems in the Treatment of Slow-Growing Tumors

  • Chapter
The Ambivalence of Cytostatic Therapy

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 52))

Abstract

The various aspects of the kinetics of slow-growing tumors in man are important in relation to the possibility of synchronization. Volume growth of many human tumors is slow compared to the tumors that grow so rapidly in small rodents. Three factors can be involved in this slow growth, and most often a combination of these factors is present. One is the prolongation of cell-cycle time, the second is the increasing fraction of cells that are not in cycle and which are not participating in the proliferation (Q-cells), and the third factor in some tumors is a significant degree of cell death. Cell death can be caused by different mechanisms; in some cells it may be due to an inherent deficiency which is incompatible with life, or it may be related to the structural environment of the tumor cells. The latter is probably the more frequent cause, and this cell death seems to be based on crowding and poor nutrition of the cells and is a direct or indirect consequence of overproduction of cells.

Some of the studies reported here were carried out in the program of the EORTC Screening and Pharmacology Group.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BARENDSEN, G. W., ROELSE, H., HERMENS, A. F., MADHUIZEN, H. T., VAN PEPER-ZEEL, H. A., RUTGERS, D. H.: Clonogenic capacity of proliferating and non- pro! iferating cells of a transplantable ratrhabdomyosarcoma. J. nat. Cancer Inst. 51, 1521 (1953).

    Google Scholar 

  2. BRUCE, W. R., MEEKER, B. E., VALERIOTE, F. A.: Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents administered in Vivo. J. nat. Cancer Inst. 37, 233 (1966).

    PubMed  CAS  Google Scholar 

  3. HERMENS, A. F.: Variations in the cell kinetics and the growth rate in an experimental tumour during natural growth and after irradiation, Thesis. Rijswijk:Radiobiological Institute TNO 1973.

    Google Scholar 

  4. HERMENS, A. F., BARENDSEN, G. W.: Changes of Cell Proliferation Characteristics in a Rat Rhabdomyosarcoma Before and After X-Irradiation. Europ. J. Cancer 5, 173 (1969).

    Article  CAS  Google Scholar 

  5. MCWILLIAMS, N. B., MAUER, A. M., LAMPKIN, B. C.: Dose dependent vincristine effects. Clin. Res. 19, 494 (1971).

    Google Scholar 

  6. MAURO, F., MADOC-JONES, H.: Age Response of Cultured Mammalian Cells to Cytotoxic Drugs. Cancer Res. 30, 1397 (1970).

    PubMed  CAS  Google Scholar 

  7. PUTTEN, L. M. van, KRAM-IDSENGA, L. K. J.: Cell-Cycle Specificity and Therapeutic Effectiveness of Cytostatic Agents. Cancer Chemother. Reports 56, 691 (1972).

    Google Scholar 

  8. PUTTEN, L. M., van, LELIEVELD, P., KRAM-IDSENGA, L. K. J.: Abhängigkeit der Wirksamkeit Phasen-spezifischer Zytostatika vom Zellzyklus; Interpretation von Dosis-Wirkungskurven. In: Aktuelle Probleme der Therapie maligner Tumoren. Ed. by: G. W. WÜST, pp.197–208. Stuttgart: Georg Thieme 1973.

    Google Scholar 

  9. REINHOLD, H. S.: Evaluation of the Radiosensitivity of Cells of a Transplantable Rhabdomyosarcoma in the Rat. Europ. J. Cancer 2, 33 (1966).

    Article  CAS  Google Scholar 

  10. STÄHELIN, H.: Reversibi1ity of the cytostatic effect of the podophyllo- toxin derivative VP 16–213. Abstract no. 150 in: Abstracts Volume B, 8th Intern. Congress of Chemotherapy, Athens (1973).

    Google Scholar 

  11. STRYCKMANS, P.: Kinetic Aspects of Leukemia Therapy. In: Cancer Chemotherapy, Ed. F. ELKERBOUT, P. THOMAS and A. ZWAVELING, p. 7. The Leiden University Press 1971.

    Google Scholar 

  12. TANNOCK, I. F.: Personal Communication 1971.

    Google Scholar 

  13. VALERIOTE, F., BRUCE, R. W.: Comparison of the Sensitivity of Hematopoietic Colony-forming Cells in different Proliferative States to Vinblastine. J. nat. Cancer Inst. 38, 393 (1967).

    PubMed  CAS  Google Scholar 

  14. VALERIOTE, F. A., TOLEN, S. J.: Survival of Hematopoietic and Lymphoma Colony forming Cells In Vivo following the Administration of a Variety of Alkylating Agents. Cancer Research 32, 470 (1972).

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

van Putten, L.M. (1975). Problems in the Treatment of Slow-Growing Tumors. In: Grundmann, E., Gross, R.W.J. (eds) The Ambivalence of Cytostatic Therapy. Recent Results in Cancer Research, vol 52. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80940-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80940-8_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-80942-2

  • Online ISBN: 978-3-642-80940-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics